^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             39    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991001    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731004 19731006 19831001    
                           19831005 19831008 19901003    
      AVISITN         4    1 4 8 12                      
      SSNRISN         2    1 2                           
      trtn            3    1 2 3                         
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     35
              Columns in Z                      0
              Subjects                         39
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read             129
          Number of Observations Used             129
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       315.34689640                
          1              2       266.30180553      0.00728359
          2              1       266.03006603      0.00041276
          3              1       266.01594807      0.00000175
          4              1       266.01589039      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5774
                UN(2,1)     id           0.2740
                UN(2,2)     id           0.6432
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,1)     id           0.2970
                UN(3,2)     id           0.5803
                UN(3,3)     id           1.0004
                UN(4,1)     id           0.3517
                UN(4,2)     id           0.2819
                UN(4,3)     id           0.5204
                UN(4,4)     id           0.5924


                        Fit Statistics

             -2 Res Log Likelihood           266.0
             AIC (Smaller is Better)         286.0
             AICC (Smaller is Better)        288.3
             BIC (Smaller is Better)         302.7
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         49.33          <.0001


                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1    31.7      54.28    <.0001
      trtn                  2    30.8       0.11    0.9001
      AVISITN               3    26.5       0.42    0.7413
      AVISITN*trtn          6    31.1       0.62    0.7129
      BASE*AVISITN          3      26       0.45    0.7204
      SSNRISN               1    29.6       2.38    0.1334
      AVISITN*SSNRISN       3    26.5       1.12    0.3589
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            1   1       -0.5409     0.2741     34
 AVISITN*trtn            1   2       -0.3378     0.2286     34
 AVISITN*trtn            1   3       -0.2297     0.2403     34
 AVISITN*trtn            4   1       -0.5451     0.2905   27.4
 AVISITN*trtn            4   2       -0.4791     0.2494     28
 AVISITN*trtn            4   3       -0.3832     0.2761   28.9
 AVISITN*trtn            8   1       -0.7076     0.3747   28.3
 AVISITN*trtn            8   2       -0.6621     0.3303   30.7
 AVISITN*trtn            8   3       -0.4338     0.3492   28.3
 AVISITN*trtn           12   1       -0.6788     0.3147   29.4
 AVISITN*trtn           12   2       -0.7805     0.2522   28.1
 AVISITN*trtn           12   3       -0.8780     0.2797   29.4

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn            1   1        -1.97     0.0566     0.05
 AVISITN*trtn            1   2        -1.48     0.1487     0.05
 AVISITN*trtn            1   3        -0.96     0.3458     0.05
 AVISITN*trtn            4   1        -1.88     0.0713     0.05
 AVISITN*trtn            4   2        -1.92     0.0649     0.05
 AVISITN*trtn            4   3        -1.39     0.1757     0.05
 AVISITN*trtn            8   1        -1.89     0.0693     0.05
 AVISITN*trtn            8   2        -2.00     0.0539     0.05
 AVISITN*trtn            8   3        -1.24     0.2243     0.05
 AVISITN*trtn           12   1        -2.16     0.0393     0.05
 AVISITN*trtn           12   2        -3.10     0.0044     0.05
 AVISITN*trtn           12   3        -3.14     0.0038     0.05

 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                   Analysis
    Effect         Visit (N)    trtn      Lower       Upper

    AVISITN*trtn            1   1       -1.0980     0.01617
    AVISITN*trtn            1   2       -0.8024      0.1268
    AVISITN*trtn            1   3       -0.7181      0.2586
    AVISITN*trtn            4   1       -1.1409     0.05062
    AVISITN*trtn            4   2       -0.9899     0.03162
    AVISITN*trtn            4   3       -0.9479      0.1815
    AVISITN*trtn            8   1       -1.4748     0.05961
    AVISITN*trtn            8   2       -1.3361     0.01183
    AVISITN*trtn            8   3       -1.1489      0.2812
    AVISITN*trtn           12   1       -1.3219    -0.03566
    AVISITN*trtn           12   2       -1.2970     -0.2641
    AVISITN*trtn           12   3       -1.4496     -0.3063
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           1  1              1  2       -0.2031
  AVISITN*trtn           1  1              1  3       -0.3112
  AVISITN*trtn           1  1              4  1      0.004200
  AVISITN*trtn           1  1              4  2      -0.06177
  AVISITN*trtn           1  1              4  3       -0.1577
  AVISITN*trtn           1  1              8  1        0.1667
  AVISITN*trtn           1  1              8  2        0.1212
  AVISITN*trtn           1  1              8  3       -0.1071
  AVISITN*trtn           1  1             12  1        0.1379
  AVISITN*trtn           1  1             12  2        0.2396
  AVISITN*trtn           1  1             12  3        0.3371
  AVISITN*trtn           1  2              1  3       -0.1081
  AVISITN*trtn           1  2              4  1        0.2073
  AVISITN*trtn           1  2              4  2        0.1413
  AVISITN*trtn           1  2              4  3       0.04538
  AVISITN*trtn           1  2              8  1        0.3698
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           1  1              1  2        0.3218
  AVISITN*trtn           1  1              1  3        0.3258
  AVISITN*trtn           1  1              4  1        0.2970
  AVISITN*trtn           1  1              4  2        0.3550
  AVISITN*trtn           1  1              4  3        0.3724
  AVISITN*trtn           1  1              8  1        0.3718
  AVISITN*trtn           1  1              8  2        0.4147
  AVISITN*trtn           1  1              8  3        0.4282
  AVISITN*trtn           1  1             12  1        0.2874
  AVISITN*trtn           1  1             12  2        0.3524
  AVISITN*trtn           1  1             12  3        0.3702
  AVISITN*trtn           1  2              1  3        0.2816
  AVISITN*trtn           1  2              4  1        0.3540
  AVISITN*trtn           1  2              4  2        0.2546
  AVISITN*trtn           1  2              4  3        0.3375
  AVISITN*trtn           1  2              8  1        0.4247
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           1  1              1  2        34    -0.63
AVISITN*trtn           1  1              1  3        34    -0.96
AVISITN*trtn           1  1              4  1      27.5     0.01
AVISITN*trtn           1  1              4  2      58.8    -0.17
AVISITN*trtn           1  1              4  3      59.4    -0.42
AVISITN*trtn           1  1              8  1      26.1     0.45
AVISITN*trtn           1  1              8  2      59.7     0.29
AVISITN*trtn           1  1              8  3        54    -0.25
AVISITN*trtn           1  1             12  1      28.7     0.48
AVISITN*trtn           1  1             12  2      53.5     0.68
AVISITN*trtn           1  1             12  3      54.9     0.91
AVISITN*trtn           1  2              1  3        34    -0.38
AVISITN*trtn           1  2              4  1      52.3     0.59
AVISITN*trtn           1  2              4  2      28.2     0.55
AVISITN*trtn           1  2              4  3        57     0.13
AVISITN*trtn           1  2              8  1      46.5     0.87
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           1  1              1  2        0.5322
  AVISITN*trtn           1  1              1  3        0.3462
  AVISITN*trtn           1  1              4  1        0.9888
  AVISITN*trtn           1  1              4  2        0.8625
  AVISITN*trtn           1  1              4  3        0.6735
  AVISITN*trtn           1  1              8  1        0.6576
  AVISITN*trtn           1  1              8  2        0.7711
  AVISITN*trtn           1  1              8  3        0.8035
  AVISITN*trtn           1  1             12  1        0.6351
  AVISITN*trtn           1  1             12  2        0.4995
  AVISITN*trtn           1  1             12  3        0.3666
  AVISITN*trtn           1  2              1  3        0.7034
  AVISITN*trtn           1  2              4  1        0.5608
  AVISITN*trtn           1  2              4  2        0.5833
  AVISITN*trtn           1  2              4  3        0.8935
  AVISITN*trtn           1  2              8  1        0.3885
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           1  1              1  2        0.05
   AVISITN*trtn           1  1              1  3        0.05
   AVISITN*trtn           1  1              4  1        0.05
   AVISITN*trtn           1  1              4  2        0.05
   AVISITN*trtn           1  1              4  3        0.05
   AVISITN*trtn           1  1              8  1        0.05
   AVISITN*trtn           1  1              8  2        0.05
   AVISITN*trtn           1  1              8  3        0.05
   AVISITN*trtn           1  1             12  1        0.05
   AVISITN*trtn           1  1             12  2        0.05
   AVISITN*trtn           1  1             12  3        0.05
   AVISITN*trtn           1  2              1  3        0.05
   AVISITN*trtn           1  2              4  1        0.05
   AVISITN*trtn           1  2              4  2        0.05
   AVISITN*trtn           1  2              4  3        0.05
   AVISITN*trtn           1  2              8  1        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           1  1              1  2       -0.8570
  AVISITN*trtn           1  1              1  3       -0.9733
  AVISITN*trtn           1  1              4  1       -0.6048
  AVISITN*trtn           1  1              4  2       -0.7721
  AVISITN*trtn           1  1              4  3       -0.9027
  AVISITN*trtn           1  1              8  1       -0.5975
  AVISITN*trtn           1  1              8  2       -0.7084
  AVISITN*trtn           1  1              8  3       -0.9655
  AVISITN*trtn           1  1             12  1       -0.4502
  AVISITN*trtn           1  1             12  2       -0.4671
  AVISITN*trtn           1  1             12  3       -0.4049
  AVISITN*trtn           1  2              1  3       -0.6803
  AVISITN*trtn           1  2              4  1       -0.5031
  AVISITN*trtn           1  2              4  2       -0.3801
  AVISITN*trtn           1  2              4  3       -0.6305
  AVISITN*trtn           1  2              8  1       -0.4850
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           1  1              1  2        0.4509
  AVISITN*trtn           1  1              1  3        0.3509
  AVISITN*trtn           1  1              4  1        0.6132
  AVISITN*trtn           1  1              4  2        0.6486
  AVISITN*trtn           1  1              4  3        0.5873
  AVISITN*trtn           1  1              8  1        0.9309
  AVISITN*trtn           1  1              8  2        0.9509
  AVISITN*trtn           1  1              8  3        0.7514
  AVISITN*trtn           1  1             12  1        0.7260
  AVISITN*trtn           1  1             12  2        0.9463
  AVISITN*trtn           1  1             12  3        1.0790
  AVISITN*trtn           1  2              1  3        0.4641
  AVISITN*trtn           1  2              4  1        0.9176
  AVISITN*trtn           1  2              4  2        0.6627
  AVISITN*trtn           1  2              4  3        0.7212
  AVISITN*trtn           1  2              8  1        1.2245
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           1  2              8  2        0.3243
  AVISITN*trtn           1  2              8  3       0.09600
  AVISITN*trtn           1  2             12  1        0.3410
  AVISITN*trtn           1  2             12  2        0.4427
  AVISITN*trtn           1  2             12  3        0.5401
  AVISITN*trtn           1  3              4  1        0.3154
  AVISITN*trtn           1  3              4  2        0.2494
  AVISITN*trtn           1  3              4  3        0.1535
  AVISITN*trtn           1  3              8  1        0.4779
  AVISITN*trtn           1  3              8  2        0.4324
  AVISITN*trtn           1  3              8  3        0.2041
  AVISITN*trtn           1  3             12  1        0.4491
  AVISITN*trtn           1  3             12  2        0.5508
  AVISITN*trtn           1  3             12  3        0.6483
  AVISITN*trtn           4  1              4  2      -0.06597
  AVISITN*trtn           4  1              4  3       -0.1619
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           1  2              8  2        0.3281
  AVISITN*trtn           1  2              8  3        0.3980
  AVISITN*trtn           1  2             12  1        0.3698
  AVISITN*trtn           1  2             12  2        0.2284
  AVISITN*trtn           1  2             12  3        0.3343
  AVISITN*trtn           1  3              4  1        0.3598
  AVISITN*trtn           1  3              4  2        0.3246
  AVISITN*trtn           1  3              4  3        0.2814
  AVISITN*trtn           1  3              8  1        0.4294
  AVISITN*trtn           1  3              8  2        0.3887
  AVISITN*trtn           1  3              8  3        0.3468
  AVISITN*trtn           1  3             12  1        0.3748
  AVISITN*trtn           1  3             12  2        0.3203
  AVISITN*trtn           1  3             12  3        0.2562
  AVISITN*trtn           4  1              4  2        0.3463
  AVISITN*trtn           4  1              4  3        0.3654
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           1  2              8  2      28.5     0.99
AVISITN*trtn           1  2              8  3      48.1     0.24
AVISITN*trtn           1  2             12  1        49     0.92
AVISITN*trtn           1  2             12  2      27.7     1.94
AVISITN*trtn           1  2             12  3      53.2     1.62
AVISITN*trtn           1  3              4  1        54     0.88
AVISITN*trtn           1  3              4  2      59.9     0.77
AVISITN*trtn           1  3              4  3      29.2     0.55
AVISITN*trtn           1  3              8  1      48.1     1.11
AVISITN*trtn           1  3              8  2      56.5     1.11
AVISITN*trtn           1  3              8  3      26.1     0.59
AVISITN*trtn           1  3             12  1      50.5     1.20
AVISITN*trtn           1  3             12  2      54.9     1.72
AVISITN*trtn           1  3             12  3      28.4     2.53
AVISITN*trtn           4  1              4  2      27.7    -0.19
AVISITN*trtn           4  1              4  3      28.5    -0.44
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           1  2              8  2        0.3312
  AVISITN*trtn           1  2              8  3        0.8104
  AVISITN*trtn           1  2             12  1        0.3610
  AVISITN*trtn           1  2             12  2        0.0629
  AVISITN*trtn           1  2             12  3        0.1121
  AVISITN*trtn           1  3              4  1        0.3846
  AVISITN*trtn           1  3              4  2        0.4452
  AVISITN*trtn           1  3              4  3        0.5895
  AVISITN*trtn           1  3              8  1        0.2713
  AVISITN*trtn           1  3              8  2        0.2706
  AVISITN*trtn           1  3              8  3        0.5613
  AVISITN*trtn           1  3             12  1        0.2364
  AVISITN*trtn           1  3             12  2        0.0912
  AVISITN*trtn           1  3             12  3        0.0172
  AVISITN*trtn           4  1              4  2        0.8503
  AVISITN*trtn           4  1              4  3        0.6610
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           1  2              8  2        0.05
   AVISITN*trtn           1  2              8  3        0.05
   AVISITN*trtn           1  2             12  1        0.05
   AVISITN*trtn           1  2             12  2        0.05
   AVISITN*trtn           1  2             12  3        0.05
   AVISITN*trtn           1  3              4  1        0.05
   AVISITN*trtn           1  3              4  2        0.05
   AVISITN*trtn           1  3              4  3        0.05
   AVISITN*trtn           1  3              8  1        0.05
   AVISITN*trtn           1  3              8  2        0.05
   AVISITN*trtn           1  3              8  3        0.05
   AVISITN*trtn           1  3             12  1        0.05
   AVISITN*trtn           1  3             12  2        0.05
   AVISITN*trtn           1  3             12  3        0.05
   AVISITN*trtn           4  1              4  2        0.05
   AVISITN*trtn           4  1              4  3        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           1  2              8  2       -0.3471
  AVISITN*trtn           1  2              8  3       -0.7042
  AVISITN*trtn           1  2             12  1       -0.4021
  AVISITN*trtn           1  2             12  2      -0.02550
  AVISITN*trtn           1  2             12  3       -0.1303
  AVISITN*trtn           1  3              4  1       -0.4060
  AVISITN*trtn           1  3              4  2       -0.3998
  AVISITN*trtn           1  3              4  3       -0.4217
  AVISITN*trtn           1  3              8  1       -0.3855
  AVISITN*trtn           1  3              8  2       -0.3460
  AVISITN*trtn           1  3              8  3       -0.5087
  AVISITN*trtn           1  3             12  1       -0.3035
  AVISITN*trtn           1  3             12  2      -0.09121
  AVISITN*trtn           1  3             12  3        0.1239
  AVISITN*trtn           4  1              4  2       -0.7756
  AVISITN*trtn           4  1              4  3       -0.9097
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           1  2              8  2        0.9957
  AVISITN*trtn           1  2              8  3        0.8962
  AVISITN*trtn           1  2             12  1        1.0840
  AVISITN*trtn           1  2             12  2        0.9109
  AVISITN*trtn           1  2             12  3        1.2106
  AVISITN*trtn           1  3              4  1        1.0367
  AVISITN*trtn           1  3              4  2        0.8987
  AVISITN*trtn           1  3              4  3        0.7287
  AVISITN*trtn           1  3              8  1        1.3412
  AVISITN*trtn           1  3              8  2        1.2108
  AVISITN*trtn           1  3              8  3        0.9169
  AVISITN*trtn           1  3             12  1        1.2016
  AVISITN*trtn           1  3             12  2        1.1928
  AVISITN*trtn           1  3             12  3        1.1726
  AVISITN*trtn           4  1              4  2        0.6437
  AVISITN*trtn           4  1              4  3        0.5859
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1              8  1        0.1625
  AVISITN*trtn           4  1              8  2        0.1170
  AVISITN*trtn           4  1              8  3       -0.1113
  AVISITN*trtn           4  1             12  1        0.1337
  AVISITN*trtn           4  1             12  2        0.2354
  AVISITN*trtn           4  1             12  3        0.3329
  AVISITN*trtn           4  2              4  3      -0.09593
  AVISITN*trtn           4  2              8  1        0.2285
  AVISITN*trtn           4  2              8  2        0.1830
  AVISITN*trtn           4  2              8  3      -0.04530
  AVISITN*trtn           4  2             12  1        0.1996
  AVISITN*trtn           4  2             12  2        0.3014
  AVISITN*trtn           4  2             12  3        0.3988
  AVISITN*trtn           4  3              8  1        0.3244
  AVISITN*trtn           4  3              8  2        0.2789
  AVISITN*trtn           4  3              8  3       0.05063
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  1              8  1        0.2695
  AVISITN*trtn           4  1              8  2        0.4116
  AVISITN*trtn           4  1              8  3        0.4263
  AVISITN*trtn           4  1             12  1        0.3313
  AVISITN*trtn           4  1             12  2        0.3691
  AVISITN*trtn           4  1             12  3        0.3875
  AVISITN*trtn           4  2              4  3        0.3301
  AVISITN*trtn           4  2              8  1        0.4225
  AVISITN*trtn           4  2              8  2        0.2451
  AVISITN*trtn           4  2              8  3        0.3966
  AVISITN*trtn           4  2             12  1        0.3866
  AVISITN*trtn           4  2             12  2        0.2722
  AVISITN*trtn           4  2             12  3        0.3553
  AVISITN*trtn           4  3              8  1        0.4382
  AVISITN*trtn           4  3              8  2        0.3981
  AVISITN*trtn           4  3              8  3        0.2486
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  1              8  1      26.2     0.60
AVISITN*trtn           4  1              8  2      43.1     0.28
AVISITN*trtn           4  1              8  3      40.4    -0.26
AVISITN*trtn           4  1             12  1      29.1     0.40
AVISITN*trtn           4  1             12  2      51.1     0.64
AVISITN*trtn           4  1             12  3      53.7     0.86
AVISITN*trtn           4  2              4  3      29.3    -0.29
AVISITN*trtn           4  2              8  1      38.5     0.54
AVISITN*trtn           4  2              8  2      28.3     0.75
AVISITN*trtn           4  2              8  3      40.5    -0.11
AVISITN*trtn           4  2             12  1      52.5     0.52
AVISITN*trtn           4  2             12  2      28.1     1.11
AVISITN*trtn           4  2             12  3      55.9     1.12
AVISITN*trtn           4  3              8  1      40.1     0.74
AVISITN*trtn           4  3              8  2      45.6     0.70
AVISITN*trtn           4  3              8  3      26.2     0.20
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  1              8  1        0.5517
  AVISITN*trtn           4  1              8  2        0.7775
  AVISITN*trtn           4  1              8  3        0.7954
  AVISITN*trtn           4  1             12  1        0.6895
  AVISITN*trtn           4  1             12  2        0.5265
  AVISITN*trtn           4  1             12  3        0.3942
  AVISITN*trtn           4  2              4  3        0.7734
  AVISITN*trtn           4  2              8  1        0.5918
  AVISITN*trtn           4  2              8  2        0.4615
  AVISITN*trtn           4  2              8  3        0.9096
  AVISITN*trtn           4  2             12  1        0.6077
  AVISITN*trtn           4  2             12  2        0.2776
  AVISITN*trtn           4  2             12  3        0.2664
  AVISITN*trtn           4  3              8  1        0.4635
  AVISITN*trtn           4  3              8  2        0.4871
  AVISITN*trtn           4  3              8  3        0.8402
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  1              8  1        0.05
   AVISITN*trtn           4  1              8  2        0.05
   AVISITN*trtn           4  1              8  3        0.05
   AVISITN*trtn           4  1             12  1        0.05
   AVISITN*trtn           4  1             12  2        0.05
   AVISITN*trtn           4  1             12  3        0.05
   AVISITN*trtn           4  2              4  3        0.05
   AVISITN*trtn           4  2              8  1        0.05
   AVISITN*trtn           4  2              8  2        0.05
   AVISITN*trtn           4  2              8  3        0.05
   AVISITN*trtn           4  2             12  1        0.05
   AVISITN*trtn           4  2             12  2        0.05
   AVISITN*trtn           4  2             12  3        0.05
   AVISITN*trtn           4  3              8  1        0.05
   AVISITN*trtn           4  3              8  2        0.05
   AVISITN*trtn           4  3              8  3        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  1              8  1       -0.3912
  AVISITN*trtn           4  1              8  2       -0.7130
  AVISITN*trtn           4  1              8  3       -0.9726
  AVISITN*trtn           4  1             12  1       -0.5437
  AVISITN*trtn           4  1             12  2       -0.5056
  AVISITN*trtn           4  1             12  3       -0.4442
  AVISITN*trtn           4  2              4  3       -0.7707
  AVISITN*trtn           4  2              8  1       -0.6265
  AVISITN*trtn           4  2              8  2       -0.3188
  AVISITN*trtn           4  2              8  3       -0.8465
  AVISITN*trtn           4  2             12  1       -0.5759
  AVISITN*trtn           4  2             12  2       -0.2561
  AVISITN*trtn           4  2             12  3       -0.3129
  AVISITN*trtn           4  3              8  1       -0.5612
  AVISITN*trtn           4  3              8  2       -0.5226
  AVISITN*trtn           4  3              8  3       -0.4601
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  1              8  1        0.7162
  AVISITN*trtn           4  1              8  2        0.9471
  AVISITN*trtn           4  1              8  3        0.7501
  AVISITN*trtn           4  1             12  1        0.8111
  AVISITN*trtn           4  1             12  2        0.9764
  AVISITN*trtn           4  1             12  3        1.1099
  AVISITN*trtn           4  2              4  3        0.5788
  AVISITN*trtn           4  2              8  1        1.0834
  AVISITN*trtn           4  2              8  2        0.6848
  AVISITN*trtn           4  2              8  3        0.7559
  AVISITN*trtn           4  2             12  1        0.9752
  AVISITN*trtn           4  2             12  2        0.8588
  AVISITN*trtn           4  2             12  3        1.1105
  AVISITN*trtn           4  3              8  1        1.2100
  AVISITN*trtn           4  3              8  2        1.0804
  AVISITN*trtn           4  3              8  3        0.5614
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  3             12  1        0.2956
  AVISITN*trtn           4  3             12  2        0.3973
  AVISITN*trtn           4  3             12  3        0.4948
  AVISITN*trtn           8  1              8  2      -0.04547
  AVISITN*trtn           8  1              8  3       -0.2738
  AVISITN*trtn           8  1             12  1      -0.02881
  AVISITN*trtn           8  1             12  2       0.07291
  AVISITN*trtn           8  1             12  3        0.1704
  AVISITN*trtn           8  2              8  3       -0.2283
  AVISITN*trtn           8  2             12  1       0.01666
  AVISITN*trtn           8  2             12  2        0.1184
  AVISITN*trtn           8  2             12  3        0.2158
  AVISITN*trtn           8  3             12  1        0.2449
  AVISITN*trtn           8  3             12  2        0.3467
  AVISITN*trtn           8  3             12  3        0.4441
  AVISITN*trtn          12  1             12  2        0.1017
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  3             12  1        0.4034
  AVISITN*trtn           4  3             12  2        0.3546
  AVISITN*trtn           4  3             12  3        0.3046
  AVISITN*trtn           8  1              8  2        0.4486
  AVISITN*trtn           8  1              8  3        0.4662
  AVISITN*trtn           8  1             12  1        0.3127
  AVISITN*trtn           8  1             12  2        0.4298
  AVISITN*trtn           8  1             12  3        0.4449
  AVISITN*trtn           8  2              8  3        0.4198
  AVISITN*trtn           8  2             12  1        0.4383
  AVISITN*trtn           8  2             12  2        0.2781
  AVISITN*trtn           8  2             12  3        0.4060
  AVISITN*trtn           8  3             12  1        0.4485
  AVISITN*trtn           8  3             12  2        0.4027
  AVISITN*trtn           8  3             12  3        0.2858
  AVISITN*trtn          12  1             12  2        0.3597
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  3             12  1      54.9     0.73
AVISITN*trtn           4  3             12  2      55.4     1.12
AVISITN*trtn           4  3             12  3      27.4     1.62
AVISITN*trtn           8  1              8  2        29    -0.10
AVISITN*trtn           8  1              8  3      28.4    -0.59
AVISITN*trtn           8  1             12  1      28.4    -0.09
AVISITN*trtn           8  1             12  2      41.3     0.17
AVISITN*trtn           8  1             12  3      43.3     0.38
AVISITN*trtn           8  2              8  3        29    -0.54
AVISITN*trtn           8  2             12  1      48.9     0.04
AVISITN*trtn           8  2             12  2      29.9     0.43
AVISITN*trtn           8  2             12  3      49.5     0.53
AVISITN*trtn           8  3             12  1      46.2     0.55
AVISITN*trtn           8  3             12  2      43.6     0.86
AVISITN*trtn           8  3             12  3      26.7     1.55
AVISITN*trtn          12  1             12  2      28.4     0.28
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  3             12  1        0.4669
  AVISITN*trtn           4  3             12  2        0.2674
  AVISITN*trtn           4  3             12  3        0.1158
  AVISITN*trtn           8  1              8  2        0.9200
  AVISITN*trtn           8  1              8  3        0.5617
  AVISITN*trtn           8  1             12  1        0.9272
  AVISITN*trtn           8  1             12  2        0.8661
  AVISITN*trtn           8  1             12  3        0.7036
  AVISITN*trtn           8  2              8  3        0.5907
  AVISITN*trtn           8  2             12  1        0.9698
  AVISITN*trtn           8  2             12  2        0.6734
  AVISITN*trtn           8  2             12  3        0.5974
  AVISITN*trtn           8  3             12  1        0.5876
  AVISITN*trtn           8  3             12  2        0.3940
  AVISITN*trtn           8  3             12  3        0.1319
  AVISITN*trtn          12  1             12  2        0.7794
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  3             12  1        0.05
   AVISITN*trtn           4  3             12  2        0.05
   AVISITN*trtn           4  3             12  3        0.05
   AVISITN*trtn           8  1              8  2        0.05
   AVISITN*trtn           8  1              8  3        0.05
   AVISITN*trtn           8  1             12  1        0.05
   AVISITN*trtn           8  1             12  2        0.05
   AVISITN*trtn           8  1             12  3        0.05
   AVISITN*trtn           8  2              8  3        0.05
   AVISITN*trtn           8  2             12  1        0.05
   AVISITN*trtn           8  2             12  2        0.05
   AVISITN*trtn           8  2             12  3        0.05
   AVISITN*trtn           8  3             12  1        0.05
   AVISITN*trtn           8  3             12  2        0.05
   AVISITN*trtn           8  3             12  3        0.05
   AVISITN*trtn          12  1             12  2        0.05
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  3             12  1       -0.5130
  AVISITN*trtn           4  3             12  2       -0.3133
  AVISITN*trtn           4  3             12  3       -0.1298
  AVISITN*trtn           8  1              8  2       -0.9630
  AVISITN*trtn           8  1              8  3       -1.2283
  AVISITN*trtn           8  1             12  1       -0.6689
  AVISITN*trtn           8  1             12  2       -0.7948
  AVISITN*trtn           8  1             12  3       -0.7267
  AVISITN*trtn           8  2              8  3       -1.0869
  AVISITN*trtn           8  2             12  1       -0.8641
  AVISITN*trtn           8  2             12  2       -0.4496
  AVISITN*trtn           8  2             12  3       -0.5999
  AVISITN*trtn           8  3             12  1       -0.6578
  AVISITN*trtn           8  3             12  2       -0.4651
  AVISITN*trtn           8  3             12  3       -0.1426
  AVISITN*trtn          12  1             12  2       -0.6346
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  3             12  1        1.1041
  AVISITN*trtn           4  3             12  2        1.1079
  AVISITN*trtn           4  3             12  3        1.1194
  AVISITN*trtn           8  1              8  2        0.8721
  AVISITN*trtn           8  1              8  3        0.6807
  AVISITN*trtn           8  1             12  1        0.6113
  AVISITN*trtn           8  1             12  2        0.9406
  AVISITN*trtn           8  1             12  3        1.0674
  AVISITN*trtn           8  2              8  3        0.6303
  AVISITN*trtn           8  2             12  1        0.8974
  AVISITN*trtn           8  2             12  2        0.6864
  AVISITN*trtn           8  2             12  3        1.0316
  AVISITN*trtn           8  3             12  1        1.1477
  AVISITN*trtn           8  3             12  2        1.1584
  AVISITN*trtn           8  3             12  3        1.0309
  AVISITN*trtn          12  1             12  2        0.8380
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn          12  1             12  3        0.1992
  AVISITN*trtn          12  2             12  3       0.09746

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn          12  1             12  3        0.3723
  AVISITN*trtn          12  2             12  3        0.3241

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn          12  1             12  3      28.8     0.53
AVISITN*trtn          12  2             12  3      28.8     0.30

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn          12  1             12  3        0.5968
  AVISITN*trtn          12  2             12  3        0.7658

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn          12  1             12  3        0.05
   AVISITN*trtn          12  2             12  3        0.05

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn          12  1             12  3       -0.5626
  AVISITN*trtn          12  2             12  3       -0.5657

 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.3.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn          12  1             12  3        0.9610
  AVISITN*trtn          12  2             12  3        0.7606
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}PGI-S: Patient Global Impression of Severity; SD: Standard 
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: PGI-S is a 5-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
